Public attitudes about equitable COVID-19 vaccine allocation: a randomised experiment of race-based versus novel place-based frames
Publication Entry
Schmidt H, Shaikh SJ, Sadecki E, Buttenheim A, Gollust S. Public attitudes about equitable COVID-19 vaccine allocation: a randomised experiment of race-based versus novel place-based frames. Journal of Medical Ethics. 2022 Dec 1;48(12):993-9.
Publication Year
Publication Type
Related News
-
Announcing the 2023 Amy Gutmann Leadership Scholars
This endowed program – created from a $2 million gift to Penn Nursing by former University of Pennsylvania President Amy Gutmann and her husband Michael Doyle – provides financial aid for exemplary undergraduate and graduate nursing students, supplementing their education with tailored learning to help shape nurse leaders who deliver exceptional evidence-based care, design research, inform policy, spark innovation, and advocate for social justice world-wide.
-
Penn Collaboratory to Fund Ten New Pilot Studies on Aging
The Penn Artificial Intelligence and Technology Collaboratory for Healthy Aging (PennAITech) – made up of Penn’s School of Nursing, the Perelman School of Medicine, and other departments across the University – focuses on identifying developing, evaluating, commercializing, and disseminating innovative technology and artificial intelligence methods/software to support aging. This is year two for the collaboratory – made possible through a grant from the National Institute on Aging – and it is providing more than $2.3 M in funding to ten pilot projects.
-
When Segregation of Opioid Use Disorder Treatment Threatens Care for People with Coexisting Conditions
Life becomes very complex for patients who need to manage pain due to cancer or other illness while still receiving methadone treatment for opioid use disorder (OUD). Methadone is a highly effective medication for treating OUD, however, the current U.S. regulatory framework mandates that methadone for OUD is exclusively accessible through federally approved Opioid Treatment Programs, with many individuals required to make daily visits for supervised dosing. This requirement places a significant burden on those with competing health needs, limited access to transportation, living in rural areas or in regions with few or no treatment programs.